Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biontech Se ADR
(NQ:
BNTX
)
100.60
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biontech Se ADR
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
61
62
Next >
BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications
March 20, 2023
From
BioNTech SE
Via
GlobeNewswire
7 Stocks Set to Soar When the Market Recovers
March 16, 2023
Daring contrarians can bid up the danger with these intriguing market ideas.
Via
InvestorPlace
BioNTech Q4 2022 Earnings Conference Call On March 27, 2023 At 08:00 AM ET
March 16, 2023
Via
Benzinga
FDA Approves Pfizer/BioNTech's Bivalent COVID-19 Vaccine For Youngest Kids
March 15, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
February 20, 2023
Via
Benzinga
Analyst Ratings for BioNTech
January 24, 2023
Via
Benzinga
Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines?
March 14, 2023
Tesla CEO Elon Musk has been a skeptic of the COVID-19 vaccines and highly critical of Dr.
Via
Benzinga
BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023
March 13, 2023
From
BioNTech SE
Via
GlobeNewswire
Wall Street Thinks These 2 Undervalued Stocks Have Exceptional Growth Potential
March 10, 2023
They're both facing the same fierce headwind, and it won't be going away soon.
Via
The Motley Fool
How Much Did US Government Spend On mRNA Vaccine Technology Before And During The Pandemic? The Number Can Be Surprising
March 03, 2023
Via
Benzinga
European Commission Keeps Mum On Talks Regarding Pfizer COVID-19 Vaccine Contract: Report
March 02, 2023
European Commission President Ursula von der Leyen remains silent on her dealings with Pfizer Inc (NYSE: PFE) regarding the EU's COVID-19 vaccine contract is hurting public trust.
Via
Benzinga
BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel
March 01, 2023
From
BioNTech SE
Via
GlobeNewswire
The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks
February 24, 2023
Startling cancer vaccine results from Moderna may point to the next big thing in biotech.
Via
Investor's Business Daily
Pfizer/BioNTech Seek Expanded Approval For Its Updated COVID-19 Shot As Primary Series Vaccination
February 24, 2023
Via
Benzinga
Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop
February 23, 2023
The company is doubling down on its vaccine success.
Via
The Motley Fool
Moderna Hypes 'Important Step' In Flu Shot Results, But Market Disagrees
February 17, 2023
Shares crumbled after Moderna's flu shot outperformed in just one flu strain.
Via
Investor's Business Daily
Why Is Moderna (MRNA) Stock Down 5% Today?
February 17, 2023
If Moderna's new formulation works the latest failure will be a short-term hiccup. But MRNA stock also faces legal and PR challenges.
Via
InvestorPlace
Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents
February 17, 2023
Via
Benzinga
Is Novavax Stock a Buy With the New Normal for COVID?
February 10, 2023
The landscape has shifted dramatically in the COVID-19 vaccine market.
Via
The Motley Fool
The 3 Most Undervalued Growth Stocks for Your February Buy List
February 06, 2023
These undervalued growth stocks have the value and projected growth that investors seek when researching their next investment decisions.
Via
InvestorPlace
Better Buy: Novavax or BioNTech Stock?
February 04, 2023
The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.
Via
The Motley Fool
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
February 02, 2023
Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.
Via
InvestorPlace
BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility
February 02, 2023
From
BioNTech SE
Via
GlobeNewswire
Novavax Shares Jumped in January While Others Slipped
February 01, 2023
Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line.
Via
MarketBeat
Exposures
COVID-19
Product Safety
Why BioNTech And Moderna Shares Are Falling After Pfizer News
January 31, 2023
BioNTech SE - ADR (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA) shares are trading lower Tuesday morning in sympathy with Pfizer Inc. (NYSE:
Via
Benzinga
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths.
Via
Benzinga
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip
January 27, 2023
The FDA's experts voted in favor of annual boosters on Thursday.
Via
Investor's Business Daily
Mergers and Acquisitions in 2023 Off To A Strong Start
January 26, 2023
Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.
Via
MarketBeat
Exposures
Product Safety
Thursday Predictions: 3 Hot Stocks for Tomorrow
January 25, 2023
Airline stocks, credit card stocks, and vaccine stocks are our focus when it comes to the hot stocks for tomorrow. Here's why.
Via
InvestorPlace
COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today
January 23, 2023
The FDA is considering a significant shift in the U.S.'s COVID-19 vaccine strategy to simplify vaccination against COVID-19.
Via
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
61
62
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.